These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23225006)

  • 41. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
    Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.
    Khurana R; Ionescu-Zanetti C; Pope M; Li J; Nielson L; Ramírez-Alvarado M; Regan L; Fink AL; Carter SA
    Biophys J; 2003 Aug; 85(2):1135-44. PubMed ID: 12885658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.
    Li SH; Li XJ
    Hum Mol Genet; 1998 May; 7(5):777-82. PubMed ID: 9536080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.
    Nucifora LG; Burke KA; Feng X; Arbez N; Zhu S; Miller J; Yang G; Ratovitski T; Delannoy M; Muchowski PJ; Finkbeiner S; Legleiter J; Ross CA; Poirier MA
    J Biol Chem; 2012 May; 287(19):16017-28. PubMed ID: 22433867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aggregation of expanded huntingtin in the brains of patients with Huntington disease.
    Hoffner G; Souès S; Djian P
    Prion; 2007; 1(1):26-31. PubMed ID: 19172113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyglutamine-rich suppressors of huntingtin toxicity act upstream of Hsp70 and Sti1 in spatial quality control of amyloid-like proteins.
    Wolfe KJ; Ren HY; Trepte P; Cyr DM
    PLoS One; 2014; 9(5):e95914. PubMed ID: 24828240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular aspects of Huntington's disease.
    Walling HW; Baldassare JJ; Westfall TC
    J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic analysis of aggregation data.
    Murphy RM
    Methods Mol Biol; 2013; 1017():201-17. PubMed ID: 23719918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid-like features of polyglutamine aggregates and their assembly kinetics.
    Chen S; Berthelier V; Hamilton JB; O'Nuallain B; Wetzel R
    Biochemistry; 2002 Jun; 41(23):7391-9. PubMed ID: 12044172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
    Hazeki N; Nakamura K; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural formation of huntingtin exon 1 aggregates probed by small-angle neutron scattering.
    Stanley CB; Perevozchikova T; Berthelier V
    Biophys J; 2011 May; 100(10):2504-12. PubMed ID: 21575585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract.
    Shen K; Calamini B; Fauerbach JA; Ma B; Shahmoradian SH; Serrano Lachapel IL; Chiu W; Lo DC; Frydman J
    Elife; 2016 Oct; 5():. PubMed ID: 27751235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyglutamine pathogenesis.
    Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the protein context on the polyglutamine length-dependent elongation of amyloid fibrils.
    Huynen C; Willet N; Buell AK; Duwez AS; Jerôme C; Dumoulin M
    Biochim Biophys Acta; 2015 Mar; 1854(3):239-48. PubMed ID: 25489872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggregation behavior of chemically synthesized, full-length huntingtin exon1.
    Sahoo B; Singer D; Kodali R; Zuchner T; Wetzel R
    Biochemistry; 2014 Jun; 53(24):3897-907. PubMed ID: 24921664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prefibrillar huntingtin oligomers isolated from HD brain potently seed amyloid formation.
    Morozova OA; Gupta S; Colby DW
    FEBS Lett; 2015 Jul; 589(15):1897-903. PubMed ID: 26037141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.